Astragaloside IV alleviates stroke-triggered early brain injury by modulating neuroinflammation and ferroptosis via the Nrf2/HO-1 signaling pathway

PURPOSE: Stroke is an acute cerebrovascular disease. Astragaloside IV (AS-IV) is an active ingredient extracted from Astragalus membranaceus with an established therapeutic effect on central nervous system diseases. This study examined the neuroprotective properties and possible mechanisms of AS-IV...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chunlei, Shi, Zhonghua, Xu, Qinyi, He, Jianqing, Chen, Lei, Lu, Zehua, Huan, Qiaohua, Wang, Yuhai, Cui, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041803/
https://www.ncbi.nlm.nih.gov/pubmed/36995819
http://dx.doi.org/10.1590/acb380723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041803/
https://www.ncbi.nlm.nih.gov/pubmed/36995819
http://dx.doi.org/10.1590/acb380723

Ejemplares similares